A comprehensive review of computational cell cycle models in guiding cancer treatment strategies.

Chenhui Ma, Evren Gurkan-Cavusoglu
Author Information
  1. Chenhui Ma: Department of Electrical, Computer and Systems Engineering, Case Western Reserve University, Cleveland, OH, USA. chenhui.ma@case.edu. ORCID
  2. Evren Gurkan-Cavusoglu: Department of Electrical, Computer and Systems Engineering, Case Western Reserve University, Cleveland, OH, USA. ORCID

Abstract

This article reviews the current knowledge and recent advancements in computational modeling of the cell cycle. It offers a comparative analysis of various modeling paradigms, highlighting their unique strengths, limitations, and applications. Specifically, the article compares deterministic and stochastic models, single-cell versus population models, and mechanistic versus abstract models. This detailed analysis helps determine the most suitable modeling framework for various research needs. Additionally, the discussion extends to the utilization of these computational models to illuminate cell cycle dynamics, with a particular focus on cell cycle viability, crosstalk with signaling pathways, tumor microenvironment, DNA replication, and repair mechanisms, underscoring their critical roles in tumor progression and the optimization of cancer therapies. By applying these models to crucial aspects of cancer therapy planning for better outcomes, including drug efficacy quantification, drug discovery, drug resistance analysis, and dose optimization, the review highlights the significant potential of computational insights in enhancing the precision and effectiveness of cancer treatments. This emphasis on the intricate relationship between computational modeling and therapeutic strategy development underscores the pivotal role of advanced modeling techniques in navigating the complexities of cell cycle dynamics and their implications for cancer therapy.

References

  1. PLoS Comput Biol. 2013;9(7):e1003120 [PMID: 23874170]
  2. Curr Opin Biotechnol. 2015 Aug;34:9-15 [PMID: 25461506]
  3. J Theor Biol. 1986 Feb 21;118(4):405-26 [PMID: 3520151]
  4. Eng Comput. 2022;38(5):4135-4149 [PMID: 36397878]
  5. NPJ Digit Med. 2022 Jun 14;5(1):77 [PMID: 35701544]
  6. Nat Rev Clin Oncol. 2019 Jul;16(7):425-441 [PMID: 30914826]
  7. PLoS Comput Biol. 2016 Sep 22;12(9):e1005093 [PMID: 27657742]
  8. Biometrics. 2005 Mar;61(1):199-207 [PMID: 15737094]
  9. Cell Cycle. 2007 Feb 15;6(4):478-88 [PMID: 17329975]
  10. Biomed Res Int. 2022 Aug 13;2022:2516653 [PMID: 36004205]
  11. CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):69-79 [PMID: 27548289]
  12. PLoS One. 2014 Jan 09;9(1):e84912 [PMID: 24416311]
  13. Curr Opin Plant Biol. 2004 Dec;7(6):661-9 [PMID: 15491914]
  14. Math Biosci Eng. 2013 Feb;10(1):1-17 [PMID: 23311359]
  15. Cancers (Basel). 2017 Jun 22;9(7): [PMID: 28640191]
  16. CPT Pharmacometrics Syst Pharmacol. 2012 Sep 26;1:e6 [PMID: 23835886]
  17. Artif Intell Rev. 2022;55(3):1947-1999 [PMID: 34393317]
  18. BMC Bioinformatics. 2006 Feb 24;7:93 [PMID: 16504125]
  19. Math Biosci. 1999 Jun;159(1):47-78 [PMID: 10361805]
  20. PLoS Comput Biol. 2008 Feb;4(2):e28 [PMID: 18282083]
  21. JCO Clin Cancer Inform. 2019 Feb;3:1-13 [PMID: 30715927]
  22. Comput Struct Biotechnol J. 2023 Oct 21;21:5285-5295 [PMID: 37941656]
  23. Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a001313 [PMID: 20182603]
  24. Curr Opin Neurobiol. 2008 Oct;18(5):472-8 [PMID: 18983918]
  25. Circulation. 2001 Jun 19;103(24):2879-81 [PMID: 11413073]
  26. PLoS Comput Biol. 2021 Jun 21;17(6):e1009080 [PMID: 34153030]
  27. Elife. 2022 Nov 15;11: [PMID: 36377847]
  28. J R Soc Interface. 2019 Aug 30;16(157):20190382 [PMID: 31431185]
  29. Ann Oncol. 2018 Feb 1;29(2):352-360 [PMID: 29069303]
  30. BMC Genomics. 2014;15 Suppl 7:S7 [PMID: 25573782]
  31. Curr Opin Biotechnol. 2010 Oct;21(5):677-82 [PMID: 20829029]
  32. Cancer Res. 2011 Apr 15;71(8):2826-37 [PMID: 21363914]
  33. Antioxid Redox Signal. 2014 Jul 10;21(2):251-9 [PMID: 24180216]
  34. J Theor Biol. 2001 Nov 7;213(1):89-101 [PMID: 11708856]
  35. Acta Biotheor. 1995 Jun;43(1-2):3-25 [PMID: 7709687]
  36. Annu Rev Nutr. 2004;24:433-53 [PMID: 15189127]
  37. J Theor Biol. 2006 Apr 7;239(3):351-66 [PMID: 16194548]
  38. Metab Eng. 2021 Jul;66:31-40 [PMID: 33813033]
  39. Sci Rep. 2019 Nov 11;9(1):16430 [PMID: 31712566]
  40. Transl Clin Pharmacol. 2019 Jun;27(2):59-63 [PMID: 32055582]
  41. Nat Rev Mol Cell Biol. 2022 Jan;23(1):74-88 [PMID: 34508254]
  42. Cancer Res. 2017 Nov 15;77(22):6442-6452 [PMID: 28923860]
  43. Cell. 2011 Mar 4;144(5):646-74 [PMID: 21376230]
  44. Brief Bioinform. 2021 Jul 20;22(4): [PMID: 33147616]
  45. Cell Stem Cell. 2019 Feb 7;24(2):213-225 [PMID: 30735649]
  46. Nat Rev Drug Discov. 2019 Jun;18(6):463-477 [PMID: 30976107]
  47. Trends Cell Biol. 2018 Nov;28(11):911-925 [PMID: 30061045]
  48. Cancer Cell. 2020 Nov 9;38(5):672-684.e6 [PMID: 33096023]
  49. Semin Cancer Biol. 1993 Apr;4(2):129-40 [PMID: 8513148]
  50. J Theor Biol. 2023 Mar 7;560:111380 [PMID: 36509138]
  51. Oncogene. 2003 Aug 11;22(33):5208-19 [PMID: 12910258]
  52. J Theor Biol. 2019 Aug 21;475:60-72 [PMID: 31128140]
  53. Biotechnol J. 2019 Nov;14(11):e1800573 [PMID: 31329373]
  54. Cytometry. 1997 Mar 1;27(3):239-49 [PMID: 9041112]
  55. Biophys J. 2008 Jul;95(1):155-65 [PMID: 18339758]
  56. Cancer Chemother Pharmacol. 2022 Sep;90(3):207-216 [PMID: 35965268]
  57. Biotechnol J. 2018 Mar;13(3):e1700229 [PMID: 29027766]
  58. J Theor Biol. 2004 Oct 21;230(4):563-79 [PMID: 15363676]
  59. J Theor Biol. 2015 Feb 21;367:262-277 [PMID: 25457229]
  60. J Math Biol. 1985;22(3):293-301 [PMID: 4067440]
  61. PLoS Comput Biol. 2022 Nov 17;18(11):e1010685 [PMID: 36395103]
  62. Bull Math Biol. 2019 Oct;81(10):3722-3731 [PMID: 31338741]
  63. Cancer Res. 2017 Dec 1;77(23):6759-6769 [PMID: 28951463]
  64. Sci Rep. 2017 Dec 5;7(1):17018 [PMID: 29208922]
  65. Immunoinformatics (Amst). 2021 Oct;1-2: [PMID: 34708216]
  66. Biol Direct. 2010 Jun 22;5:41 [PMID: 20569476]
  67. Cell Cycle. 2013 Oct 1;12(19):3203-18 [PMID: 24013422]
  68. Cancers (Basel). 2023 May 13;15(10): [PMID: 37345087]
  69. Biophys J. 2005 Dec;89(6):3884-94 [PMID: 16199495]
  70. PLoS Comput Biol. 2023 Apr 21;19(4):e1011070 [PMID: 37083821]
  71. BMC Bioinformatics. 2006 Nov 09;7:494 [PMID: 17094799]
  72. J Math Biol. 2008 Jul;57(1):91-110 [PMID: 18064465]
  73. J Math Biol. 2020 Jan;80(1-2):205-273 [PMID: 31865403]
  74. J R Soc Interface. 2013 Jun 12;10(85):20130325 [PMID: 23760298]
  75. J Bacteriol. 1980 Jun;142(3):808-18 [PMID: 6991494]
  76. Drug Resist Updat. 2021 Dec;59:100796 [PMID: 34953682]
  77. Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30566-30576 [PMID: 33203674]
  78. CPT Pharmacometrics Syst Pharmacol. 2023 Mar;12(3):360-374 [PMID: 36642831]
  79. Bioinformatics. 2023 Jun 1;39(6): [PMID: 37289551]
  80. J Theor Biol. 2007 Jan 7;244(1):96-107 [PMID: 16949103]
  81. Bull Math Biol. 2020 Jan 14;82(1):11 [PMID: 31933029]
  82. Nat Ecol Evol. 2023 Apr;7(4):581-596 [PMID: 36894662]
  83. Cell Tissue Kinet. 1984 Nov;17(6):609-18 [PMID: 6488278]
  84. SAGE Open Med. 2021 Dec 23;9:20503121211067083 [PMID: 34992782]
  85. Cell Rep. 2017 May 16;19(7):1351-1364 [PMID: 28514656]
  86. PLoS Comput Biol. 2013;9(12):e1003358 [PMID: 24339759]
  87. Essays Biochem. 2008;45:83-94 [PMID: 18793125]
  88. Curr Biol. 2019 Jan 21;29(2):350-358.e4 [PMID: 30639107]
  89. J Theor Biol. 2017 Sep 21;429:204-228 [PMID: 28647496]
  90. Cancer Res. 2022 Apr 15;82(8):1503-1517 [PMID: 35255118]
  91. PLoS Comput Biol. 2014 Jul 24;10(7):e1003616 [PMID: 25058870]
  92. Nat Commun. 2019 Nov 19;10(1):5221 [PMID: 31745082]
  93. Front Pharmacol. 2016 Nov 15;7:421 [PMID: 27895579]
  94. Cell. 2014 Jan 30;156(3):603-616 [PMID: 24485463]
  95. Elife. 2021 May 13;10: [PMID: 33983115]
  96. Proc Natl Acad Sci U S A. 1973 Apr;70(4):1263-7 [PMID: 4515625]
  97. Nat Med. 2021 Dec;27(12):2065-2066 [PMID: 34824458]
  98. Sci Rep. 2021 Jan 13;11(1):925 [PMID: 33441727]
  99. Genome Med. 2014 Jul 30;6(7):57 [PMID: 25165489]
  100. Cytometry A. 2014 Sep;85(9):785-97 [PMID: 24894899]
  101. Mol Cancer Ther. 2009 Jan;8(1):45-54 [PMID: 19139112]
  102. Curr Opin Biotechnol. 2011 Oct;22(5):604-10 [PMID: 21353523]
  103. Front Oncol. 2020 Apr 22;10:569 [PMID: 32391266]
  104. J Chem Phys. 2005 Feb 1;122(5):54103 [PMID: 15740306]
  105. FEBS J. 2021 Jun;288(12):3813-3833 [PMID: 33030287]
  106. Sci Rep. 2016 Mar 01;6:22498 [PMID: 26928089]
  107. Stem Cells Int. 2018 May 2;2018:4598195 [PMID: 29853913]
  108. Int J Cancer. 2023 Apr 15;152(8):1510-1525 [PMID: 36093588]
  109. BMC Syst Biol. 2016 Aug 11;10(1):73 [PMID: 27515956]
  110. Cell. 1980 Feb;19(2):493-504 [PMID: 7357616]
  111. PLoS Comput Biol. 2011 Feb 10;7(2):e1001077 [PMID: 21347318]
  112. Front Bioinform. 2021 Apr 29;1:639349 [PMID: 36303766]
  113. PLoS One. 2010 Sep 30;5(9): [PMID: 20941358]
  114. Oncogene. 2008 Oct 6;27(45):5904-12 [PMID: 18836471]
  115. Curr Biol. 2016 Feb 8;26(3):356-61 [PMID: 26776734]
  116. BMC Bioinformatics. 2017 Jan 17;18(1):39 [PMID: 28095781]
  117. Front Oncol. 2021 Nov 24;11:712505 [PMID: 34900668]
  118. J Mol Cell Biol. 2011 Feb;3(1):1-3 [PMID: 21278445]
  119. J Math Biol. 2003 Oct;47(4):295-312 [PMID: 14523574]
  120. J Cancer Res Clin Oncol. 2023 Aug;149(9):5475-5477 [PMID: 36795194]
  121. Mol Syst Biol. 2019 Mar 18;15(3):e8604 [PMID: 30886052]
  122. Bull Math Biol. 2005 Jul;67(4):815-30 [PMID: 15893554]
  123. EBioMedicine. 2021 Jul;69:103448 [PMID: 34186491]
  124. Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21643-8 [PMID: 20007375]
  125. Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):1036-53 [PMID: 17692993]
  126. J Theor Biol. 2016 Mar 21;393:203-17 [PMID: 26780652]
  127. Sci Rep. 2021 Sep 17;11(1):18524 [PMID: 34535748]
  128. J Theor Biol. 2023 Jul 21;569:111533 [PMID: 37196820]
  129. Annu Rev Pharmacol Toxicol. 2007;47:357-400 [PMID: 17067280]
  130. BMC Syst Biol. 2012 Aug 29;6:116 [PMID: 22932419]
  131. Bull Math Biol. 2007 Jul;69(5):1673-90 [PMID: 17361361]
  132. Nat Commun. 2021 Mar 25;12(1):1850 [PMID: 33767176]
  133. Annu Rev Microbiol. 1968;22:519-48 [PMID: 4879521]
  134. J Cheminform. 2013 Jun 22;5(1):30 [PMID: 23800010]
  135. Drug Discov Today. 2017 Nov;22(11):1680-1685 [PMID: 28881183]
  136. Math Biosci. 2007 Sep;209(1):292-315 [PMID: 17306310]
  137. Am J Physiol Cell Physiol. 2003 Feb;284(2):C349-64 [PMID: 12388094]
  138. Trends Biochem Sci. 2019 Jun;44(6):490-501 [PMID: 30655165]
  139. Comput Math Methods Med. 2014;2014:206287 [PMID: 25140193]
  140. J Theor Biol. 2008 Oct 21;254(4):850-60 [PMID: 18703074]
  141. N Engl J Med. 2021 Oct 14;385(16):1445-1447 [PMID: 34623789]
  142. BioData Min. 2017 Jun 17;10:20 [PMID: 28638442]
  143. Biophys J. 2006 Jun 15;90(12):4361-79 [PMID: 16581849]
  144. PLoS One. 2014 Jan 03;9(1):e83962 [PMID: 24404145]
  145. Brief Bioinform. 2018 Nov 27;19(6):1382-1399 [PMID: 28981626]
  146. PLoS Biol. 2019 Apr 30;17(4):e3000228 [PMID: 31039152]
  147. Curr Opin Biotechnol. 2014 Aug;28:111-5 [PMID: 24556244]
  148. MedComm (2020). 2023 May 22;4(3):e265 [PMID: 37229486]
  149. Phys Med Biol. 2005 Jan 7;50(1):93-102 [PMID: 15715425]
  150. Mol Syst Biol. 2014 Mar 28;10:722 [PMID: 24682507]
  151. J Theor Biol. 2019 Jan 14;461:276-290 [PMID: 30352237]
  152. J Theor Biol. 2023 Feb 7;558:111371 [PMID: 36462667]
  153. Curr Opin Immunol. 2014 Apr;27:16-25 [PMID: 24531241]
  154. Comput Biol Chem. 2015 Apr;55:1-13 [PMID: 25601491]
  155. Bull Math Biol. 2017 Dec;79(12):2905-2928 [PMID: 29030804]
  156. Math Biosci. 2006 Aug;202(2):349-70 [PMID: 16697424]
  157. Clin Cancer Res. 2014 Jul 15;20(14):3763-74 [PMID: 24850847]
  158. BMC Bioinformatics. 2007 Nov 26;8:462 [PMID: 18039375]
  159. PLoS Comput Biol. 2023 Jun 6;19(6):e1011156 [PMID: 37279246]
  160. Elife. 2020 Jan 23;9: [PMID: 31971512]
  161. Dev Cell. 2020 Nov 9;55(3):259-271 [PMID: 33171109]
  162. Cancer Metastasis Rev. 2007 Jun;26(2):319-31 [PMID: 17458507]
  163. J Chem Inf Model. 2014 Sep 22;54(9):2562-9 [PMID: 25116798]
  164. Semin Cancer Biol. 2015 Dec;35 Suppl:S25-S54 [PMID: 25892662]
  165. Angew Chem Int Ed Engl. 2010 Jun 7;49(25):4170-98 [PMID: 20518023]
  166. Oncogene. 2004 May 20;23(23):4187-92 [PMID: 15048079]
  167. Biosystems. 2011 Mar;103(3):384-91 [PMID: 21095219]
  168. PLoS Comput Biol. 2019 Mar 15;15(3):e1006402 [PMID: 30875364]
  169. J Theor Biol. 2010 Sep 7;266(1):124-39 [PMID: 20515697]
  170. Cell Cycle. 2019 Apr;18(8):795-808 [PMID: 30870080]
  171. J Theor Biol. 2011 May 21;277(1):7-18 [PMID: 21333658]
  172. Front Mol Biosci. 2022 Dec 23;9:1056461 [PMID: 36619168]
  173. Exp Cell Res. 1977 Jul;107(2):377-86 [PMID: 872891]
  174. Nature. 2021 Feb;590(7847):649-654 [PMID: 33627808]
  175. Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19701-6 [PMID: 22106268]
  176. PLoS Comput Biol. 2023 May 1;19(5):e1011082 [PMID: 37126527]
  177. Curr Opin Biotechnol. 2018 Jun;51:97-102 [PMID: 29275251]
  178. J Invest Dermatol. 2016 Jul;136(7):1479-1489 [PMID: 26970356]
  179. Cell Prolif. 2003 Jun;36(3):131-49 [PMID: 12814430]
  180. Nat Rev Cancer. 2017 Jan 27;17(2):93-115 [PMID: 28127048]
  181. Chaos. 2001 Mar;11(1):277-286 [PMID: 12779461]
  182. Biosystems. 2006 May;84(2):91-100 [PMID: 16434137]
  183. Cancer Cell Int. 2021 Jan 20;21(1):62 [PMID: 33472628]
  184. Int J Mol Sci. 2019 Feb 15;20(4): [PMID: 30781344]
  185. Cell Cycle. 2010 Jun 1;9(11):2102-7 [PMID: 20505362]
  186. PLoS Comput Biol. 2022 Jul 22;18(7):e1010254 [PMID: 35867773]
  187. Cancers (Basel). 2021 Dec 29;14(1): [PMID: 35008317]
  188. PLoS Comput Biol. 2013 Oct;9(10):e1003286 [PMID: 24250280]
  189. Curr Oncol Rep. 2021 Jul 16;23(9):107 [PMID: 34269904]
  190. FEBS J. 2021 Nov;288(21):6286-6303 [PMID: 33190412]
  191. Bull Math Biol. 2012 Mar;74(3):736-67 [PMID: 22083513]
  192. PLoS Comput Biol. 2017 May 3;13(5):e1005529 [PMID: 28467408]
  193. J Theor Biol. 2019 May 21;469:47-60 [PMID: 30836073]
  194. Front Bioeng Biotechnol. 2020 Aug 07;8:942 [PMID: 32850764]
  195. Biol Lett. 2018 May;14(5): [PMID: 29769297]
  196. Sci Rep. 2018 Jun 11;8(1):8903 [PMID: 29891989]
  197. Math Biosci. 1996 Oct 1;137(1):25-50 [PMID: 8854661]
  198. Biotechnol Bioeng. 2008 Mar 1;99(4):960-74 [PMID: 17787014]
  199. J Chem Phys. 2012 Jan 21;136(3):034105 [PMID: 22280742]
  200. PLoS One. 2016 May 17;11(5):e0153738 [PMID: 27187804]
  201. J Clin Med. 2020 May 02;9(5): [PMID: 32370195]
  202. Nat Commun. 2022 Jun 21;13(1):3555 [PMID: 35729113]
  203. Elife. 2019 Nov 26;8: [PMID: 31769410]
  204. Cell Prolif. 1999 Oct;32(5):321-35 [PMID: 10619492]
  205. Oncogene. 2002 May 13;21(21):3403-13 [PMID: 12032778]
  206. Front Immunol. 2024 Mar 07;15:1358019 [PMID: 38515743]
  207. Mol Cell Biol. 1999 Aug;19(8):5785-99 [PMID: 10409765]
  208. PLoS One. 2014 Jan 09;9(1):e83477 [PMID: 24416166]
  209. Curr Opin Cell Biol. 1995 Dec;7(6):835-42 [PMID: 8608014]
  210. Oncogene. 2003 Sep 1;22(37):5834-47 [PMID: 12947390]
  211. Chem Soc Rev. 2016 Sep 21;45(18):4929-52 [PMID: 27396271]
  212. J Theor Biol. 2012 May 21;301:122-40 [PMID: 22342935]
  213. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5032-7 [PMID: 17360353]
  214. Comput Methods Programs Biomed. 2022 Sep;224:106974 [PMID: 35834900]
  215. Nat Rev Clin Oncol. 2010 Aug;7(8):455-65 [PMID: 20531380]
  216. Science. 2010 Sep 24;329(5999):1616-20 [PMID: 20929839]
  217. Front Bioeng Biotechnol. 2021 Jan 14;8:621269 [PMID: 33520972]
  218. J Theor Biol. 2000 Dec 7;207(3):431-41 [PMID: 11082311]
  219. Cancer Biol Med. 2017 Nov;14(4):348-362 [PMID: 29372101]
  220. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7491-5 [PMID: 1323840]
  221. Biochem Eng J. 2001 Jan;7(1):49-68 [PMID: 11150796]
  222. Science. 2002 Aug 16;297(5584):1183-6 [PMID: 12183631]
  223. Pharm Res. 2022 Aug;39(8):1669-1680 [PMID: 35552984]
  224. Bioinformatics. 2006 Jul 15;22(14):e124-31 [PMID: 16873462]
  225. Clin Chem. 1993 Nov;39(11 Pt 2):2375-85 [PMID: 8222249]
  226. J Math Biol. 2016 Apr;72(5):1301-36 [PMID: 26094055]
  227. J R Soc Interface. 2022 Apr;19(189):20210903 [PMID: 35382573]
  228. Comput Struct Biotechnol J. 2021 Sep 02;19:5170-5183 [PMID: 34630937]
  229. Mutat Res. 2020 May - Dec;821:111695 [PMID: 32304909]
  230. Nature. 2003 Apr 10;422(6932):633-7 [PMID: 12687005]
  231. Comput Math Methods Med. 2012;2012:960256 [PMID: 22852024]
  232. J Theor Biol. 2012 Sep 7;308:1-19 [PMID: 22659352]
  233. Pharm Res. 2019 Feb 22;36(4):57 [PMID: 30796530]
  234. J R Soc Interface. 2014 May 07;11(96):20140206 [PMID: 24806707]
  235. FASEB J. 1993 Sep;7(12):1188-91 [PMID: 8375618]
  236. J Math Biol. 2009 Apr;58(4-5):689-721 [PMID: 18941752]
  237. Bioessays. 2018 Jan;40(1): [PMID: 29168203]
  238. NPJ Syst Biol Appl. 2023 Oct 30;9(1):54 [PMID: 37903760]
  239. Bioinformatics. 2019 Apr 1;35(7):1188-1196 [PMID: 30169736]
  240. Cancer Res. 2001 Apr 15;61(8):3230-9 [PMID: 11309271]
  241. Int J Clin Pharmacol Ther. 1997 Oct;35(10):401-13 [PMID: 9352388]
  242. J Math Biol. 2015 Dec;71(6-7):1663-703 [PMID: 25814336]
  243. Bull Math Biol. 2012 Feb;74(2):300-26 [PMID: 21681605]
  244. Nat Rev Cancer. 2008 Jan;8(1):56-61 [PMID: 18059462]
  245. PLoS Comput Biol. 2018 Mar 26;14(3):e1005985 [PMID: 29579036]
  246. Eur J Pharm Sci. 2009 Jan 31;36(1):20-38 [PMID: 19041394]
  247. Cell Mol Life Sci. 2013 Nov;70(21):4009-21 [PMID: 23508805]
  248. Trends Pharmacol Sci. 2003 Mar;24(3):139-45 [PMID: 12628359]
  249. Bioinformatics. 2004 Jul 10;20(10):1506-11 [PMID: 15231543]
  250. Semin Cancer Biol. 2015 Dec;35 Suppl:S5-S24 [PMID: 25869442]
  251. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2776-8 [PMID: 9096291]
  252. EBioMedicine. 2021 Jun;68:103396 [PMID: 34049239]
  253. Int J Mol Sci. 2021 Jun 28;22(13): [PMID: 34203270]
  254. J Cell Sci. 1993 Dec;106 ( Pt 4):1153-68 [PMID: 8126097]
  255. Genes Dis. 2023 Jan 14;11(1):189-204 [PMID: 37588236]
  256. Nat Commun. 2018 Jun 20;9(1):2419 [PMID: 29925878]
  257. J Pharmacokinet Pharmacodyn. 2015 Oct;42(5):477-96 [PMID: 26252969]
  258. Curr Opin Oncol. 1999 Jan;11(1):68-75 [PMID: 9914881]
  259. PLoS Comput Biol. 2016 Jan 07;12(1):e1004604 [PMID: 26741131]
  260. Mol Biol Cell. 1998 Dec;9(12):3273-97 [PMID: 9843569]
  261. Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3473-3478 [PMID: 28289232]
  262. Int J Mol Sci. 2022 Sep 26;23(19): [PMID: 36232625]
  263. Cell Commun Signal. 2020 Apr 7;18(1):59 [PMID: 32264958]
  264. PLoS One. 2019 Nov 11;14(11):e0224787 [PMID: 31710617]
  265. Interface Focus. 2014 Jun 6;4(3):20130075 [PMID: 24904738]
  266. Clin Pharmacol Ther. 2021 Mar;109(3):605-618 [PMID: 32686076]
  267. Annu Rev Biophys. 2018 May 20;47:251-271 [PMID: 29517919]
  268. Cancers (Basel). 2021 Aug 28;13(17): [PMID: 34503172]
  269. Science. 2009 Nov 27;326(5957):1216-9 [PMID: 19965464]
  270. PLoS Comput Biol. 2017 Jan 23;13(1):e1005331 [PMID: 28114351]
  271. Cancers (Basel). 2011 Mar 15;3(1):1351-71 [PMID: 24212665]
  272. Sci Rep. 2022 Jul 4;12(1):11289 [PMID: 35789162]
  273. CPT Pharmacometrics Syst Pharmacol. 2017 Jan;6(1):11-20 [PMID: 27863176]
  274. Front Oncol. 2020 Sep 10;10:1552 [PMID: 33042800]
  275. Cell. 2011 Mar 18;144(6):874-85 [PMID: 21414480]
  276. Trends Cell Biol. 2002 Sep;12(9):432-8 [PMID: 12220864]
  277. Genome Inform. 2010;24:1-20 [PMID: 22081585]
  278. PLoS One. 2014 May 13;9(5):e97130 [PMID: 24824602]
  279. Cancers (Basel). 2020 Jul 28;12(8): [PMID: 32731592]
  280. Interface Focus. 2011 Feb 6;1(1):24-35 [PMID: 22419972]
  281. Clin Cancer Res. 2001 Aug;7(8):2168-81 [PMID: 11489790]
  282. BMC Syst Biol. 2011 Nov 08;5:187 [PMID: 22067083]
  283. BMC Bioinformatics. 2019 Dec 16;20(Suppl 26):628 [PMID: 31839008]
  284. PLoS Comput Biol. 2013;9(10):e1003293 [PMID: 24146610]
  285. Chin J Cancer. 2012 Feb;31(2):100-9 [PMID: 22237039]
  286. Transl Oncol. 2022 Feb;16:101332 [PMID: 34973570]
  287. Cell Rep. 2017 Nov 21;21(8):2236-2250 [PMID: 29166613]
  288. Comb Chem High Throughput Screen. 2017;20(7):603-611 [PMID: 28413974]
  289. Bioinformatics. 2014 May 1;30(9):1331-2 [PMID: 24443380]
  290. Target Oncol. 2009 Apr;4(2):143-7 [PMID: 19377851]
  291. BMC Bioinformatics. 2019 Jun 20;20(Suppl 12):322 [PMID: 31216979]
  292. BMC Syst Biol. 2012 Sep 15;6:125 [PMID: 22979979]
  293. Bioinformatics. 2010 May 15;26(10):1378-80 [PMID: 20378558]
  294. Brief Bioinform. 2005 Jun;6(2):163-77 [PMID: 15975225]
  295. Mol Biol Cell. 2005 Jan;16(1):421-32 [PMID: 15537702]
  296. J Theor Biol. 2019 Feb 7;462:490-498 [PMID: 30468760]
  297. Front Oncol. 2022 Jun 23;12:891652 [PMID: 35814435]
  298. Phys Biol. 2019 Dec 03;17(1):016004 [PMID: 31722323]
  299. Nature. 2015 Mar 26;519(7544):468-71 [PMID: 25762143]
  300. Cancer Discov. 2022 Jan;12(1):31-46 [PMID: 35022204]
  301. Cell Cycle. 2010 Mar 1;9(5):886-91 [PMID: 20160487]
  302. Nature. 2007 Aug 23;448(7156):947-51 [PMID: 17713537]
  303. Curr Biol. 2004 Sep 21;14(18):R771-7 [PMID: 15380091]
  304. Drug Discov Today. 2023 Jul;28(7):103605 [PMID: 37146963]
  305. J Oncol. 2019 Oct 31;2019:2403483 [PMID: 31814825]
  306. BMC Syst Biol. 2017 Dec 06;11(1):122 [PMID: 29212542]
  307. PLoS One. 2008 Feb 27;3(2):e1672 [PMID: 18301750]
  308. J Theor Biol. 2010 Jun 7;264(3):771-81 [PMID: 20303984]
  309. Stem Cells Dev. 2009 Apr;18(3):377-85 [PMID: 18752377]
  310. PLoS Comput Biol. 2018 Feb 23;14(2):e1005991 [PMID: 29474446]
  311. BMC Syst Biol. 2017 Jul 11;11(1):68 [PMID: 28693495]
  312. Cancer Res. 2009 May 15;69(10):4484-92 [PMID: 19366802]
  313. Oncotarget. 2014 Jul 30;5(14):5674-85 [PMID: 25010037]
  314. BMC Bioinformatics. 2019 Jul 2;20(1):370 [PMID: 31266445]
  315. FEBS J. 2012 Sep;279(18):3411-31 [PMID: 22458764]
  316. Asian J Androl. 2012 Mar;14(2):270-7 [PMID: 22231293]
  317. J Theor Biol. 2022 Jul 21;545:111104 [PMID: 35337794]
  318. Nat Commun. 2023 Jun 10;14(1):3450 [PMID: 37301933]
  319. Cell Rep. 2017 Sep 19;20(12):2784-2791 [PMID: 28930675]
  320. J Pharmacokinet Pharmacodyn. 2015 Apr;42(2):179-89 [PMID: 25588379]
  321. PLoS Comput Biol. 2016 Dec 9;12(12):e1005230 [PMID: 27935947]
  322. Nat Cell Biol. 2003 Apr;5(4):346-51 [PMID: 12629549]
  323. Biotechnol Prog. 2007 Sep-Oct;23(5):1198-209 [PMID: 17691814]
  324. Mol Cell. 2021 Jul 15;81(14):2975-2988.e6 [PMID: 34157308]
  325. Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):15912-7 [PMID: 25349411]
  326. Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4781-6 [PMID: 15037758]
  327. Cold Spring Harb Perspect Biol. 2010 Oct;2(10):a003236 [PMID: 20719876]
  328. BMC Syst Biol. 2017 Oct 3;11(Suppl 5):90 [PMID: 28984196]
  329. J Math Biol. 2009 Apr;58(4-5):657-87 [PMID: 18841363]
  330. Theor Biol Med Model. 2007 Dec 21;4:50 [PMID: 18154660]
  331. FEBS J. 2017 Feb;284(3):362-375 [PMID: 27634578]
  332. J Am Stat Assoc. 2013;108(503): [PMID: 24363476]
  333. J Math Biol. 2004 Oct;49(4):329-57 [PMID: 15657794]
  334. J Theor Biol. 2018 Oct 7;454:253-267 [PMID: 29909142]
  335. Cell Syst. 2020 Aug 26;11(2):161-175.e5 [PMID: 32726596]
  336. J R Soc Interface. 2020 Jul;17(168):20200360 [PMID: 32634365]
  337. EMBO Rep. 2014 Dec;15(12):1243-53 [PMID: 25381661]
  338. Nat Commun. 2017 Aug 22;8(1):321 [PMID: 28831039]
  339. Sci Signal. 2018 Jul 24;11(540): [PMID: 30042127]
  340. Sci Rep. 2021 May 27;11(1):11122 [PMID: 34045495]
  341. Genes (Basel). 2014 Mar 06;5(1):147-75 [PMID: 24705291]
  342. Annu Rev Cell Dev Biol. 2009;25:377-406 [PMID: 19575646]
  343. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4008-13 [PMID: 17360468]
  344. Math Med Biol. 2012 Mar;29(1):95-108 [PMID: 21147846]
  345. J Theor Biol. 2006 Jul 7;241(1):120-33 [PMID: 16387327]
  346. IEEE J Biomed Health Inform. 2019 May;23(3):1304-1315 [PMID: 30010603]
  347. FEBS Lett. 2015 Aug 19;589(18):2304-11 [PMID: 26188547]
  348. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12295-300 [PMID: 18713859]
  349. FEBS Lett. 2019 Oct;593(19):2742-2750 [PMID: 31283008]
  350. Cell Metab. 2016 Nov 8;24(5):685-700 [PMID: 27829138]
  351. Processes (Basel). 2019 Jan;7(1): [PMID: 30701168]
  352. Eur J Med Chem. 2022 Apr 15;234:114239 [PMID: 35290843]
  353. Biometrics. 2010 Jun;66(2):567-77 [PMID: 19508238]
  354. PLoS One. 2018 Oct 26;13(10):e0206292 [PMID: 30365511]
  355. Curr Protoc. 2021 Jun;1(6):e151 [PMID: 34101381]

MeSH Term

Humans
Neoplasms
Cell Cycle
Models, Biological
Computer Simulation
Signal Transduction
Tumor Microenvironment
Antineoplastic Agents
Computational Biology

Chemicals

Antineoplastic Agents

Word Cloud

Created with Highcharts 10.0.0modelscomputationalmodelingcellcyclecanceranalysisdrugarticlevariousversusdynamicstumoroptimizationtherapyreviewreviewscurrentknowledgerecentadvancementsofferscomparativeparadigmshighlightinguniquestrengthslimitationsapplicationsSpecificallycomparesdeterministicstochasticsingle-cellpopulationmechanisticabstractdetailedhelpsdeterminesuitableframeworkresearchneedsAdditionallydiscussionextendsutilizationilluminateparticularfocusviabilitycrosstalksignalingpathwaysmicroenvironmentDNAreplicationrepairmechanismsunderscoringcriticalrolesprogressiontherapiesapplyingcrucialaspectsplanningbetteroutcomesincludingefficacyquantificationdiscoveryresistancedosehighlightssignificantpotentialinsightsenhancingprecisioneffectivenesstreatmentsemphasisintricaterelationshiptherapeuticstrategydevelopmentunderscorespivotalroleadvancedtechniquesnavigatingcomplexitiesimplicationscomprehensiveguidingtreatmentstrategies

Similar Articles

Cited By